In conclusion, BBF prevented IAA-induced toxicity in HT22 cells and MCAO-induced neurological and behavioral abnormity in rats, possibly via the inhibition of the ERK and GSK3β pathways, indicating the potential use of BBF for treating ischemic stroke. This evidence concerns the gene GSK3B and ischemic stroke.